Austedo XR 36 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FXLG8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,681
Award facts
- Contract value 100% obligated
- $39,680.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,680.94 to AmerisourceBergen Drug Corp for the supply of AUSTEDO XR 36 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AUSTEDO XR is a prescription medication used in the treatment of tardive dyskinesia and chorea associated with Huntington's disease, representing a specialty pharmaceutical product within the Defense Health System's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and active through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's continued role as a primary pharmaceutical distributor for federal medical procurement reflects its established capability to meet competitive procurement requirements across multiple therapeutic domains for Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXLG8?
SPE2DB25FXLG8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FXLG8 worth?
The government has obligated $39,681 on SPE2DB25FXLG8.
Is contract SPE2DB25FXLG8 an order under another contract?
Yes. SPE2DB25FXLG8 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXLG8 competed?
The extent of competition for SPE2DB25FXLG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award